Glofitamab Monotherapy Provides Durable Responses after Fixed-Length Dosing in Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) Patients (pts)
Year: 2021
Type: conference-abstract
Source: Blood
Authors: Michael Dickinson, Carmelo Carlo-Stella, Franck Morschhauser, Krish Patel, Cyrus Khan, Nancy L. Bartlett, Gloria Iacoboni, Mark Hertzberg, Sirpa Leppä, Eric Van Den Neste, Monica Tani, Guillaume Cartron, Antonio Salar, David Perez-Callejo, Linda Lundberg, James Relf, Emma Clark, Kathryn Humphrey, Martin Hutchings
Institutions: The Royal Melbourne Hospital, The University of Melbourne, Peter MacCallum Cancer Centre, Humanitas University, IRCCS Humanitas Research Hospital, Université de Lille, Allegheny Health Network, Washington University in St. Louis, Alvin J. Siteman Cancer Center, Vall d'Hebron Hospital Universitari, Prince of Wales Hospital, University of Helsinki, Helsinki University Hospital, Cliniques Universitaires Saint-Luc, Ospedale "Santa Maria delle Croci" di Ravenna, Centre Hospitalier Universitaire de Montpellier, Hospital Del Mar, Roche (Switzerland), Roche (United Kingdom), Rigshospitalet
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3214636619